BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33144180)

  • 1. WHO classification of meningiomas-A single institutional experience.
    Salami AA; Okunlola AI; Ajani MA; Onakpoma F
    Neurochirurgie; 2021 Apr; 67(2):119-124. PubMed ID: 33144180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.
    Simon M; Boström J; Koch P; Schramm J
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):767-73. PubMed ID: 16306156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiopathological classification of dural tail sign of meningiomas.
    Qi ST; Liu Y; Pan J; Chotai S; Fang LX
    J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The accuracy of meningioma grading: a 10-year retrospective audit.
    Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
    Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical meningiomas: WHO moved the goalposts?
    Smith SJ; Boddu S; Macarthur DC
    Br J Neurosurg; 2007 Dec; 21(6):588-92. PubMed ID: 18071986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
    Delgado-López PD; Corrales-García EM
    Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histopathological spectrum of human meningiomas.
    Backer-Grøndahl T; Moen BH; Torp SH
    Int J Clin Exp Pathol; 2012; 5(3):231-42. PubMed ID: 22558478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
    Sá-Marta E; Alves JL; Rebelo O; Barbosa M
    World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relevance of Simpson's grading system for resections in WHO grade I meningiomas].
    Otero A; Tabernero MD; Muñoz MC; Sousa P; Miranda D; Pascual D; Gonçalves JM; Ruiz L
    Neurocirugia (Astur); 2017; 28(4):176-182. PubMed ID: 28242156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World Health Organization grade II meningiomas.
    Champeaux C; Dunn L
    Acta Neurochir (Wien); 2016 May; 158(5):921-9; discussion 929. PubMed ID: 27020441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
    Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
    J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological classification and molecular genetics of meningiomas.
    Riemenschneider MJ; Perry A; Reifenberger G
    Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between malignant subtypes of meningioma and clinical outcome.
    Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
    J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraorbital meningiomas: a pathologic review using current World Health Organization criteria.
    Jain D; Ebrahimi KB; Miller NR; Eberhart CG
    Arch Pathol Lab Med; 2010 May; 134(5):766-70. PubMed ID: 20441509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of age on the histological grading of meningiomas.
    Park JS; Sade B; Oya S; Kim CG; Lee JH
    Neurosurg Rev; 2014 Jul; 37(3):425-9; discussion 429. PubMed ID: 24777642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.